Skip to main content
. 2023 Mar 6;28(5):2400. doi: 10.3390/molecules28052400

Figure 3.

Figure 3

BTK pathway. BCL10—B-cell lymphoma/leukemia 10 protein, BCR—B cell receptor, CAM—calmodulin, CARD11—caspase recruitment domain-containing protein 11, CN—calcineurin, CXCR4—chemokine receptor type 4, DAG—diacylglycerol, ERK1/2—extracellular signal-regulated protein kinase ½, IKK—inhibitor of NF-κB kinase, IP3—inositol 1,4,5-trisphosphate, MALT1—mucosa-associated lymphoid tissue lymphoma translocation protein 1, MAPK—mitogen-activated protein kinase, MEK1/2—MAPK/ERK kinase ½, MYC—transcription factor, MYD88—myeloid differentiation primary response protein 88, NFAT—nuclear factor of activated T-cells, NF-кB—nuclear factor kappa-light-chain-enhancer of activated B-cells, PKCβ—protein kinase C β, PLCγ2—phospholipase Cγ2, RAS—rat sarcoma virus GTPase, SRC—protooncogene tyrosine-protein kinase, TLR—toll-like receptor.